Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
1-Year Return
24.55%
This Quarter Return
+9.64%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$20.3B
AUM Growth
+$1.22B
(+6.4%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60
Top Buys
| 1 |
TE
T1 Energy Inc.
TE
|
+$62.5M |
| 2 |
Pfizer
PFE
|
+$52.4M |
| 3 |
GXO Logistics
GXO
|
+$37.7M |
| 4 |
Fair Isaac
FICO
|
+$28.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$28.4M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$61.1M |
| 2 |
Ameresco
AMRC
|
+$56.4M |
| 3 |
Alibaba
BABA
|
+$46.6M |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$41.5M |
| 5 |
Wolfspeed
WOLF
|
+$41.2M |
Sector Composition
| 1 | Technology | 25.22% |
| 2 | Healthcare | 17.92% |
| 3 | Consumer Discretionary | 13.84% |
| 4 | Financials | 12.08% |
| 5 | Industrials | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Andersons Inc
ANDE
$1.4B
| $334K | ﹤0.01% |
8,623
-300
| -3% | -$11.6K |
|
|
CERE
1577
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $334K | ﹤0.01% |
+10,300
| New | +$334K |
|
1578
BridgeBio Pharma
BBIO
$10.4B
| $333K | ﹤0.01% |
19,950
-4,800
| -19% | -$80.1K |
|
1579
Steelcase
SCS
$1.98B
| $333K | ﹤0.01% |
28,418
| – | – |
|
1580
8x8 Inc
EGHT
$285M
| $331K | ﹤0.01% |
19,725
-325,000
| -94% | -$5.45M |
|
|
UHT
1581
Universal Health Realty Income Trust
UHT
$568M
| $331K | ﹤0.01% |
5,565
| – | – |
|
1582
Palomar
PLMR
$3.32B
| $330K | ﹤0.01% |
5,100
| – | – |
|
1583
LendingTree
TREE
$1.01B
| $329K | ﹤0.01% |
2,686
| – | – |
|
1584
IMAX
IMAX
$1.67B
| $328K | ﹤0.01% |
18,395
| – | – |
|
|
TBI
1585
Trueblue
TBI
$174M
| $327K | ﹤0.01% |
11,816
| – | – |
|
1586
Atlanta Braves Holdings Series B
BATRK
$2.66B
| $325K | ﹤0.01% |
11,560
| – | – |
|
1587
Sonos
SONO
$1.78B
| $325K | ﹤0.01% |
10,900
-19,700
| -64% | -$587K |
|
1588
ACM Research
ACMR
$1.73B
| $324K | ﹤0.01% |
11,400
-5,100
| -31% | -$145K |
|
1589
Alector
ALEC
$279M
| $324K | ﹤0.01% |
15,700
-1,100
| -7% | -$22.7K |
|
|
ACCD
1590
DELISTED
Accolade, Inc. Common Stock
ACCD
| $324K | ﹤0.01% |
12,300
| – | – |
|
1591
Repay Holdings
RPAY
$509M
| $323K | ﹤0.01% |
17,700
| – | – |
|
1592
Worthington Enterprises
WOR
$3.23B
| $323K | ﹤0.01% |
9,596
-5,352
| -36% | -$180K |
|
1593
Madrigal Pharmaceuticals
MDGL
$10.1B
| $322K | ﹤0.01% |
3,800
+1,100
| +41% | +$93.2K |
|
1594
FibroGen
FGEN
$45.1M
| $321K | ﹤0.01% |
912
+144
| +19% | +$50.7K |
|
1595
PROS Holdings
PRO
$755M
| $321K | ﹤0.01% |
9,300
| – | – |
|
|
IMGN
1596
DELISTED
Immunogen Inc
IMGN
| $321K | ﹤0.01% |
43,300
| – | – |
|
|
SRNE
1597
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $321K | ﹤0.01% |
69,100
+7,800
| +13% | +$36.2K |
|
1598
Westamerica Bancorp
WABC
$1.26B
| $319K | ﹤0.01% |
5,530
| – | – |
|
1599
The GEO Group
GEO
$2.93B
| $317K | ﹤0.01% |
40,900
| – | – |
|
1600
Globalstar
GSAT
$4.81B
| $316K | ﹤0.01% |
18,160
-17,320
| -49% | -$301K |
|